血脂变异性与心血管疾病的研究进展  

Research advance in blood lipid variability and cardiovascular disease

作　　者：王国峰 吕舒 肖金潭 刘伯芹 Wang Guofeng;Lyu Shu;Xiao Jintan;Liu Boqin(Department of Cardiology,Qingdao Municipal Hospital,Qingdao 266002,China)

机构地区：[1]青岛市市立医院心内科,266002

出　　处：《中国心血管杂志》2025年第2期227-231,共5页Chinese Journal of Cardiovascular Medicine

摘　　要：血脂异常是动脉粥样硬化性心血管疾病发生的重要危险因素。血脂变异性升高促进动脉粥样硬化进展、增加急性冠脉事件、心房颤动、心力衰竭等心脏不良事件的发生。监测血脂水平达标的同时更注重血脂平稳达标和长期达标,这对进一步降低心血管疾病的发生发展有重要意义。Dyslipidemia is an important risk factor for the development of atherosclerotic cardiovascular disease.Elevated blood lipid variability accelerates the progression of atherosclerosis and increases the occurrence of adverse cardiac events such as acute coronary events,atrial fibrillation and heart failure.Monitoring the target achievement of blood lipid and paying more attention to stable and long-term target achievement of blood lipid may be of great significance for further reducing the occurrence and development of cardiovascular disease.

关 键 词：心血管疾病 血脂异常 血脂变异性 动脉粥样硬化 急性冠脉综合征 心力衰竭 心房颤动 

分 类 号：R54[医药卫生—心血管疾病]